In the EPHB6-high expression group, the activities of steps 1, 4, and 7 in the cancer immunity cycle were weakened from the perspective of molecular functions, which implies that the activities of cancer cell antigen release and immune cells tracking tumor cells were restricted. The gene discussed is EPHB6; the disease is cancer.